Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

14.21 -0.02 (-0.11%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

24 25 Next >

5 OTC Stocks With The Potential To Explode In 2024 ↗

November 08, 2023

Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from and available investing platforms.

Via Benzinga

Analyst Expectations for Iovance Biotherapeutics's Future ↗

November 08, 2023

Via Benzinga

Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2023 Financial Results and Corporate Updates

November 07, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Earnings Preview: Iovance Biotherapeutics ↗

November 06, 2023

Via Benzinga

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023

October 31, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Why Shares of Iovance Biotherapeutics Jumped Monday ↗

September 18, 2023

The company's stock rally began on Friday.

Via The Motley Fool

Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

October 31, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

October 20, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Tesla, Nokia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

October 19, 2023

U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Advanced Mucosal Melanoma at the European Society for Medical Oncology (ESMO) Congress

October 16, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race

October 10, 2023

Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...

Via PressReach

Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

September 27, 2023

Four-year Analysis of C-144-01 Trial Cohorts 2 and 4

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

September 22, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

September 18, 2023

Via Benzinga

Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

September 18, 2023

Gainers

Via Benzinga

Over $26M Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying ↗

September 18, 2023

Although U.S. stocks closed lower on Friday, there were a few notable insider trades.

Via Benzinga

Alteryx, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

September 18, 2023

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session. Newegg Commerce, Inc. (NASDAQ: NEGG) shares climbed 8.7% to...

Via Benzinga

Why Iovance Biotherapeutics Stock Rocketed 13% Higher Today ↗

September 15, 2023

The approval process for the biotech's most advanced pipeline drug program is going quite well, it seems.

Via The Motley Fool

Personalized Skin Cancer Therapy, Despite FDA Delay: Analysts Show Confidence In Iovance Biotherapeutics Therapy ↗

September 15, 2023

Thursday, the FDA extended the review period for Iovance Biotherapeutics Inc's (NASDAQ: IOVA) marketing application seeking accelerated approval for lifileucel

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 15, 2023

Via Benzinga

Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

September 15, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results.

Via Benzinga

Nasdaq Down Over 1%; US Industrial Output Rises In August ↗

September 15, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% points on Friday. The Dow traded down 0.52% to 34,727.05 while the NASDAQ fell 1.31% to 13,743.78. The...

Via Benzinga

Topics Stocks

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) is One of Friday Morning’s Most Active Stocks

September 15, 2023

Via Investor Brand Network

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 15, 2023

Via Benzinga

Why Volcon Shares Are Trading Lower By 19%; Here Are 20 Stocks Moving Premarket ↗

September 15, 2023

Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares rose 38.7% to $0.1421 in pre-market trading after gaining 10% on Thursday.

Via Benzinga

Mitek Systems, Arm Holdings And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗

September 15, 2023

U.S. stock futures traded mostly higher this morning on Friday. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

U.S. Food and Drug Administration Updates Prescription Drug User Fee Act (PDUFA) Action Date for Lifileucel for the Treatment of Advanced Melanoma

September 14, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Why Shares of Iovance Biotherapeutics Dropped Thursday ↗

September 14, 2023

The biotech stock's lead therapy is looking at some competition.

Via The Motley Fool

Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 14, 2023

Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 89.5% to $0.8243 after the company announced license agreement for capeserod from Sanofi.

Via Benzinga

Iovance Biotherapeutics Stock Is Down 15%: What's Going On? ↗

September 14, 2023

Iovance Biotherapeutics Inc (NASDAQ: IOVA) shares are trading lower by 15.8% to $4.58, despite a lack of company-specific news for the session.

Via Benzinga

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.